208 related articles for article (PubMed ID: 24028749)
1. Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; Hou MY; Borgatta L
Contraception; 2013 Nov; 88(5):671-3. PubMed ID: 24028749
[TBL] [Abstract][Full Text] [Related]
2. Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; McClusky J; Hou MY; Borgatta L
Contraception; 2015 Feb; 91(2):174-7. PubMed ID: 25481376
[TBL] [Abstract][Full Text] [Related]
3. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
4. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
Mark A; Sonalkar S; Borgatta L
Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
[TBL] [Abstract][Full Text] [Related]
5. Intra-abortion contraception with etonogestrel subdermal implant.
Barros Pereira I; Carvalho RM; Graça LM
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():33-5. PubMed ID: 25522115
[TBL] [Abstract][Full Text] [Related]
6. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
Raymond EG; Weaver MA; Tan YL; Louie KS; Bousiéguez M; Lugo-Hernández EM; Aranguré-Peraza AG; Sanhueza P; Kaplan C; Sonalkar S; Goldberg AB; Culwell KR; Memmel L; Jamshidi R; Winikoff B
Obstet Gynecol; 2016 Feb; 127(2):306-12. PubMed ID: 26942358
[TBL] [Abstract][Full Text] [Related]
7. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
8. Progestin-based contraceptive on the same day as medical abortion.
Park J; Robinson N; Wessels U; Turner J; Geller S
Int J Gynaecol Obstet; 2016 May; 133(2):217-20. PubMed ID: 26868071
[TBL] [Abstract][Full Text] [Related]
9. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
10. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
[TBL] [Abstract][Full Text] [Related]
11. Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses.
Schmidt-Hansen M; Hawkins JE; Lord J; Williams K; Lohr PA; Hasler E; Cameron S
Hum Reprod Update; 2020 Feb; 26(2):141-160. PubMed ID: 32096862
[TBL] [Abstract][Full Text] [Related]
12. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
13. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?
Tocce KM; Sheeder JL; Teal SB
Am J Obstet Gynecol; 2012 Jun; 206(6):481.e1-7. PubMed ID: 22631865
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
[TBL] [Abstract][Full Text] [Related]
15. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
[TBL] [Abstract][Full Text] [Related]
17. The contraceptive implant for long acting reversible contraception in patients undergoing first trimester medical termination of pregnancy.
Church E; Sengupta S; Chia KV
Sex Reprod Healthc; 2010 Aug; 1(3):105-9. PubMed ID: 21122606
[TBL] [Abstract][Full Text] [Related]
18. Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study.
Di Carlo C; Sansone A; De Rosa N; Gargano V; Tommaselli GA; Nappi C; Bifulco G
Gynecol Endocrinol; 2014 Jan; 30(1):53-6. PubMed ID: 24131079
[TBL] [Abstract][Full Text] [Related]
19. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
Riney S; O'Shea B; Forde A
Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
[TBL] [Abstract][Full Text] [Related]
20. Home or office etonogestrel implant insertion after pregnancy: a randomized trial.
Uhm S; Pope R; Schmidt A; Bazella C; Perriera L
Contraception; 2016 Nov; 94(5):567-571. PubMed ID: 27373542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
